Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Post-Transplant Complications

Outbreaks of infectious diseases in stem cell transplant units: a silent cause of death for patients and transplant programmes

Summary:

Following the closure of the National Blood and Bone Marrow Transplant Unit in Dublin, because of an outbreak of vancomycin-resistant enterococcal infection, a survey was carried out by the EBMT to investigate the occurrence of outbreaks of infection in SCT units and the impact on patient morbidity, mortality and the administration of the transplant programme over a 10-year period from 1991 to 2001. A total of 13 centres reported 23 outbreaks of infection involving 231 patients: 10 bacterial, eight viral and five fungal outbreaks were reported and 56 deaths were attributed to infection. All fungal and bacterial deaths and the majority of viral deaths occurred in allograft recipients. In all outbreaks, the infection was reported to be hospital acquired and in all the viral, and half the bacterial infections, cross-infection was a major factor. All viral, four of 10 bacterial and three of five fungal outbreaks occurred in HEPA filtered rooms. A total of 12 SCT units reported a partial or total closure. The introduction of mandatory quality management systems such as JACIE should result in a change in attitude to ‘incident reporting’ and together with future surveys should reduce the incidence of infectious outbreaks in SCT units.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1

Similar content being viewed by others

References

  1. Donnelly JP . Bacterial complications of transplantation: diagnosis and treatment. J Antimicrob Chemother 1995; 36: 59–72.

    Article  CAS  PubMed  Google Scholar 

  2. Jantunen E, Ruutu P, Niskanen L et al. Incidence and risk factors for invasive fungal infection in allogeneic BMT recipients. Bone Marrow Transplant 1997; 19: 801–808.

    Article  CAS  PubMed  Google Scholar 

  3. Bostrom L, Ringden O . Viral infections. Clinical bone marrow and blood stem cell transplantation. In: Atkinson K (ed.). Major Transplant Related Problems, Part VIII. Cambridge University Press: Cambridge, 2000, pp 758–782.

    Google Scholar 

  4. Offner F, Cordonnier C, Ljungman P, et al., on behalf of the EBMT-EORTC Joint Project on Aspergillosis prior to BMT. Impact of previous aspergillosis on the outcome of bone marrow transplantation. Clin Infect Dis 1998; 26: 1098–1103.

    Article  CAS  PubMed  Google Scholar 

  5. Gerson SL, Talbot GH, Hurwitz S et al. Prolonged granulocytopenia: the major risk factor for invasive pulmonary aspergillosis in patients with acute leukaemia. Ann Intern Med 1984; 100: 345.

    Article  CAS  PubMed  Google Scholar 

  6. Sayer HG, Longton G, Bowden R et al. Increased risk of infection in marrow transplant patients receiving methylprednisolone for graft-vs-host disease prevention. Blood 1994; 84: 1328.

    CAS  PubMed  Google Scholar 

  7. Giralt S . Complications of non-myeloablative stem cell transplantation. In: Giralt S, Slavin S (eds.). Non-myeloablative stem cell transplantation (NST). Darwin Scientific Publishing Limited: Oxfordshire, UK, 2000, pp 139–148.

    Google Scholar 

  8. Birchard K . Irish bone marrow transplant unit closes. Lancet 2000; 356: 1012.

    Article  Google Scholar 

  9. Gratwohl A, McCann S, Byrne JL et al. Outbreaks of infectious disease in stem cell transplant units: a silent cause of death for patients and transplant programmes. Bone Marrow Transplant 2002; 29 (Suppl. 2): 303.

    Google Scholar 

  10. Cornet M, Levy V, Lortholary J et al. Efficacy of prevention by high-efficiency particulate air filtration or laminar airflow against Aspergillus airborne contamination during hospital renovation. Infect Control Hosp Epidemiol 1999; 20: 508–513.

    Article  CAS  PubMed  Google Scholar 

  11. Sherertz RJ, Belani A, Kramer BS, Elfenbein GJ . Impact of air filtration on nosocomial aspergillus infections unique risk of bone marrow transplant recipients. Am J Med 1987; 83: 709.

    Article  CAS  PubMed  Google Scholar 

  12. Dykewicz CA . Hospital infection control of hematopoietic stem cell transplant recipients. Centres for Disease Control and Prevention, Atlanta, GA, USA 2001; 7: 2.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Withington S, Chambers ST, Beard ME et al. Invasive aspergillosis in severely neutropenic patients over 18 years; impact of intranasal amphotericin B and HEPA filtration. J Hosp Infect 1998; 38: 11.

    Article  CAS  PubMed  Google Scholar 

  14. Wald A, Leisenring W, von Burik JA, Bowden RA . Epidemiology of Aspergillus infections in a large cohort of patients undergoing bone marrow transplantation. J Infect Dis 1997; 175: 1459.

    Article  CAS  PubMed  Google Scholar 

  15. Streifel AJ, Marshall JW . Parameters for ventilation controlled environments in hospitals. In: Moschandreas DJ (ed.). Design, Construction and Operation of Healthy Buildings. Solutions to Global and Regional Concerns. American Society of Heating, Refrigeration and Air-Conditioning Engineers Press: Atlanta, 1998, pp 305–309.

    Google Scholar 

  16. Opal SM, Asp AA, Cannady PB et al. Efficacy of infection control measures during a nosocomial outbreak of disseminated aspergillosis associated with hospital construction. J Infect Dis 1986; 153: 634–637.

    Article  CAS  PubMed  Google Scholar 

  17. Anaissie EJ, Costa SF . Nosocomial aspergillosis is waterborne. Clin Infect Dis 2001; 33: 1546–1548.

    Article  CAS  PubMed  Google Scholar 

  18. Weems JJ, Davis Jr BJ, Tablan OC et al. Construction activity: an independent risk factor for invasive aspergillosis and zygomycosis in patients with hematologic malignancy. Infect Control 1987; 8: 71–75.

    Article  PubMed  Google Scholar 

  19. Wingard JR, Beals SU, Santos GW et al. Aspergillus infections in bone marrow transplant recipients. Bone Marrow Transplant 1987; 2: 175.

    CAS  PubMed  Google Scholar 

  20. Chazalet V, Debeaupuis JP, Sarfati J et al. Molecular typing of environmental and patient isolates of Aspergillus fumigatus from various hospital settings. J Clin Miocrobiol 1998; 36: 1494–1500.

    CAS  Google Scholar 

  21. Hospenthal DR, Kwon-Chung KJ, Bennet JE . Concentrations of airborne Aspergillus compared to the incidence of invasive aspergillosis: lack of correlation. Med Mycol 1998; 36: 165–168.

    Article  CAS  PubMed  Google Scholar 

  22. Vesley D, Streifel AJ . Environmental services. In: Mayhall CB (ed.). Hospital Epidemiology and Infection Control, 2nd edn. Lippincott, Williams & Wilkins: Philadelphia, 1999, pp 1047–1053.

    Google Scholar 

  23. Garner JS . The Hospital Infection Control Practices Advisory Committee Guideline for isolation precautions in hospitals. Infect Control Hosp Epidemiol 1996; 17: 1–80.

    Article  Google Scholar 

  24. CDC. Recommendations for preventing opportunistic infections in stem cell transplant recipients; recommendations of the Infectious Disease Society of America and the American Society of Blood and Bone Marrow. Morb Mortal Wkly Rep 2000; 49: 1–128.

  25. Passweg JR, Rowlings PA, Atkinson KA et al. Influence of protective isolation on outcome of allogeneic bone marrow transplantation for leukaemia. Bone Marrow Transplant 1998; 21: 1231.

    Article  CAS  PubMed  Google Scholar 

  26. Barbaric D, Shaw PJ . Scedosporium infection in immunocompromised patients: successful use of liposomal amphotericin B and intraconazole. Med Pediatr Oncol 2000; 37: 122–125.

    Article  Google Scholar 

  27. Alvarez M, Ponga BL, Rayon C et al. Nosocomial outbreak caused by Scedosporium prolificans (inflatum): four fatal cases in leukaemia patients. J Clin Microbiol 1995; 33: 3290–3295.

    CAS  PubMed  PubMed Central  Google Scholar 

  28. Orth B, Frei R, Itin PH et al. Outbreak of invasive mycoses caused by Paecilomyces lilancinus from a contaminated skin lotion. Ann Intern Med 1996; 125: 799–806.

    Article  CAS  PubMed  Google Scholar 

  29. Zambon M, Bull T, Sadler CJ et al. Molecular epidemiology of two consecutive outbreaks of parainfluenza 3 in a bone marrow transplant unit. J Clin Microbiol 1998; 36: 2289–2293.

    CAS  PubMed  PubMed Central  Google Scholar 

  30. Lewis VA, Champlin R, Englund J et al. Respiratory disease due to parainfluenza virus in adult bone marrow transplant recipients. Clin Infect Dis 1996; 23: 1033–1037.

    Article  CAS  PubMed  Google Scholar 

  31. Wendt CH, Weisdorf DJ, Jordan MC et al. Parainfluenza virus respiratory infection after bone marrow transplantation. N Engl J Med 1992; 326: 921–926.

    Article  CAS  PubMed  Google Scholar 

  32. Whimpey E, Vartivarian SE, Champlin RE et al. Parainfluenza virus infection in adult bone marrow transplant recipients. Eur J Clin Microbiol 1993; 19: 699–701.

    Article  Google Scholar 

  33. Garcia R, Raad I, Abi-Said D et al. Nosocomial respiratory syncytial virus infections. Infect Control Hosp Epidemiol 1997; 18: 412–416.

    Article  CAS  PubMed  Google Scholar 

  34. Champlin E, Whimbey E . Community respiratory virus infections in bone marrow transplant recipients: The M.D. Anderson Cancer Center Experience. Biol Blood Marrow Transplant 2001; 7: 8S–10S.

    Article  PubMed  Google Scholar 

  35. Harrington R, Hooton TM, Hackman RC et al. An outbreak of respiratory syncytial virus in a bone marrow transplant center. J Infect Dis 1992; 165: 987–993.

    Article  CAS  PubMed  Google Scholar 

  36. Cubitt WD, Mitchell DK, Carter MJ et al. Application of electronmicroscopy, enzyme immunoassay, and RT-PCR to monitor an outbreak of astrovirus type 1 in a paediatric bone marrow transplant unit. J Med Virol 1999; 57: 313–321.

    Article  CAS  PubMed  Google Scholar 

  37. Hall C . Respiratory syncytial virus and parainfluenza virus. N Engl J Med 2001; 344: 1917–1928.

    Article  CAS  PubMed  Google Scholar 

  38. Whimbey E, Ghosh S . Respiratory syncytial virus infections in immuno-compromised adults. Curr Clin Top Infect Dis 2000; 20: 232–255.

    CAS  PubMed  Google Scholar 

  39. Wendt CH, Hertz MI . Respiratory syncytial virus and parainfluenza virus infections in the immunocompromised host. Semin Respir Infect 1995; 10: 224–231.

    CAS  PubMed  Google Scholar 

  40. Knowles S, Herra C, Devitt E et al. An outbreak of multiply resistant Serratia marcescens: the importance of persistent carriage. Bone Marrow Transplant 2000; 25: 873–877.

    Article  CAS  PubMed  Google Scholar 

  41. Klausner JD, Zukerman C, Limaye AP, Corey L . Outbreak of Stenrophomonas maltophilia bacteremia among patients undergoing bone marrow transplantation: association with faulty replacement of handwashing soap. Infect Control Hosp Epidemiol 1999; 20: 756–758.

    Article  CAS  PubMed  Google Scholar 

  42. Murray BE . Vancomycin-resistant enterococci. Am J Med 1997; 102: 284–293.

    Article  CAS  PubMed  Google Scholar 

  43. Uttley AHC, Collins CH, Naidoo J, George RC . Vancomycin-resistant enterococci. Lancet 1988; 1: 57–58.

    Article  CAS  PubMed  Google Scholar 

  44. McAlister T, George N, Faoagali J, Bell J . Isolation of β-lactamase positive vancomycin resistant Enterococcus faecalis; first case in Australia. Commun Dis Intell 1999; 23: 237–239.

    CAS  PubMed  Google Scholar 

  45. Kirpatrick BD, Harrington SM, Smith D et al. An outbreak of vancomycin-dependent Enterococcus faecium in a bone marrow transplant unit. Clin Infect Dis 1999; 29: 1268–1273.

    Article  Google Scholar 

  46. CDC. Recommendations for preventing the spread of vancomycin resistance; recommendations of the hospital infection control practices advisory committee. Morb Mortal Wkly Rep 1995; 44: 1–13.

Download references

Acknowledgements

We thank the following for completing the questionnaire and for providing data: P Browne, St James's Hospital, Dublin, Ireland; JL Byrne, Nottingham City Hospital, Nottingham, UK; C Cordonnier, Hopital Henri Mondor, Paris, France; A Gratwohl, Kantonsspital, Basel, Switzerland; P Ljungman, Huddinge University Hospital, Huddinge, Sweden; S Mackinnon, University College Hospital, London, UK; E Olavarria, Imperial College School of Medicine, London, UK; P Ribaud, Hopital Saint-Louis, Paris, France; M Rovira, Hospital Clinic, Barcelona, Spain; P Shaw, The New Children's Hospital, Sydney, Australia; S Sica, Universita Cattolica, S Cuore, Rome, Italy; P Trabasso, Cicade Universitaria Zeferino Vaz, Sao Paolo, Brazil; MT Van Lint, Ospedale San Martino, Genoa, Italy; L Volin, Helsinki University Central PO, Helsinki, Finland; and K Ward, Windeyer Building, London, UK. We also thank the Department of Microbiology and Infection Control in St James's Hospital, Dublin for the detailed information on the VRE outbreak in Dublin. We also thank the PHLS, Central Public Health Laboratories, Colindale, for carrying out the molecular typing of enterococci.

Author information

Authors and Affiliations

Authors

Consortia

Corresponding author

Correspondence to S McCann.

Appendices

Appendix A

Figure 2

figure 2

Figure 2

Appendix B

Figure 3

figure 3

Figure 3

Rights and permissions

Reprints and permissions

About this article

Cite this article

McCann, S., Byrne, J., Rovira, M. et al. Outbreaks of infectious diseases in stem cell transplant units: a silent cause of death for patients and transplant programmes. Bone Marrow Transplant 33, 519–529 (2004). https://doi.org/10.1038/sj.bmt.1704380

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.bmt.1704380

Keywords

This article is cited by

Search

Quick links